Skip to main content
. Author manuscript; available in PMC: 2023 Aug 1.
Published in final edited form as: Lancet Oncol. 2022 Jul 7;23(8):1009–1020. doi: 10.1016/S1470-2045(22)00369-2

Figure 3. Waterfall plot of best responses of the 77 patients with measurable disease at study start.

Figure 3.

Panel A shows best responses of the 39 patients with baseline measurable disease in the nira/nivo arm. Panel B shows best responses of the 38 patients with baseline measurable disease in the nira/ipi arm.